RAPP
Rapport Therapeutics, Inc.
27.02
+1.06 (+4.08%)
52w low 22.06
52.93 high
16.1% of range
Financial Analysis
| Ratio | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Sep 26 | Trend |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating Margin | -- | -- | -121.1% | -- | -- | |
| EBITDA Margin | -- | -- | -119.9% | -- | -- | |
| Net Margin | -- | -- | -99.3% | -- | -- | |
| FCF Margin | -- | -- | -65.7% | -- | -- | |
| Returns | ||||||
| Return on Equity | -5.3% | -7.0% | -4.2% | -13.4% | -10.3% | |
| Return on Assets | -5.0% | -6.6% | -4.0% | -12.3% | -9.6% | |
| Return on Inv Capital | -4.6% | -6.3% | -4.1% | -11.4% | -8.9% | |
| Liquidity | ||||||
| Current Ratio | 36.37x | 26.17x | 27.08x | 15.72x | 20.07x | |
| Quick Ratio | 36.37x | 26.17x | 27.08x | 15.72x | 20.07x | |
| Cash Ratio | 17.56x | 2.76x | 4.36x | 2.24x | 3.68x | |
| Leverage | ||||||
| Debt / Equity | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | |
| Equity Multiplier | 1.05x | 1.06x | 1.06x | 1.09x | 1.07x | |
| Efficiency | ||||||
| Asset Turnover | 0.00x | 0.00x | 0.04x | 0.00x | 0.00x | |
| Op CF / Net Income | 0.65x | 0.73x | 0.66x | 0.73x | 1.03x | |
| Investment | ||||||
| Capex / Revenue | -- | -- | 0.4% | -- | -- | |
| R&D / Revenue | -- | -- | 163.6% | -- | -- | |
| SG&A / Revenue | -- | -- | 57.5% | -- | -- | |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--